US Stock MarketDetailed Quotes
KURA Kura Oncology
- 20.280
- +0.660+3.36%
Close May 1 16:00 ET
1.54BMarket Cap-9750P/E (TTM)
20.810High19.630Low754.61KVolume19.630Open19.620Pre Close15.25MTurnover1.51%Turnover RatioLossP/E (Static)76.18MShares24.17052wk High3.89P/B1.01BFloat Cap7.41052wk Low--Dividend TTM49.85MShs Float43.000Historical High--Div YieldTTM6.01%Amplitude2.500Historical Low20.215Avg Price1Lot Size
Kura Oncology Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -13.41%-124.82M | -29.32%-34.31M | -38.16%-29.03M | 15.57%-25.62M | -11.47%-35.87M | -5.27%-110.06M | -13.54%-26.53M | 14.57%-21.01M | -8.08%-30.34M | -12.85%-32.18M |
| Net income from continuing operations | -12.36%-152.63M | -29.21%-42.79M | -8.73%-38.6M | -6.92%-37.17M | -4.98%-34.07M | -4.12%-135.84M | -1.13%-33.11M | -6.41%-35.5M | -3.29%-34.77M | -5.73%-32.45M |
| Depreciation and amortization | 11.86%849K | 3.88%214K | 11.92%216K | 16.39%213K | 16.38%206K | 36.02%759K | 24.10%206K | 20.63%193K | 47.58%183K | 63.89%177K |
| Other non cash items | 553.42%477K | --119K | --122K | --121K | --115K | -81.70%73K | ---- | ---- | ---- | ---- |
| Change In working capital | 362.21%7.82M | 2,309.74%3.71M | -33.51%5.04M | 307.59%6.35M | 4.96%-7.28M | 7.51%-2.98M | -90.36%154K | 478.32%7.58M | -34.31%-3.06M | -98.52%-7.66M |
| -Change in prepaid assets | 33.22%-1.96M | -287.43%-2.53M | -12.28%800K | 173.30%1.88M | 19.81%-2.11M | -722.13%-2.94M | 19.54%1.35M | 34.51%912K | -470.17%-2.57M | 8.04%-2.63M |
| -Change in payables and accrued expense | 1,387.66%10.33M | 590.13%7.65M | -38.08%3.93M | 1,306.16%4.11M | -2.15%-5.36M | 68.15%-802K | -5,132.26%-1.56M | 4,468.35%6.35M | 72.41%-341K | -261.64%-5.25M |
| -Change in other current assets | -219.96%-685K | -524.06%-1.46M | 19.48%276K | 388.18%317K | 76.19%185K | 273.56%571K | -17.27%345K | -46.53%231K | 93.07%-110K | -74.39%105K |
| -Change in other current liabilities | -25.54%137K | 264.71%62K | -65.06%29K | 189.19%33K | -89.26%13K | 1,020.00%184K | -10.53%17K | 36.07%83K | 74.66%-37K | 163.04%121K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -13.41%-124.82M | -29.32%-34.31M | -38.16%-29.03M | 15.57%-25.62M | -11.47%-35.87M | -5.27%-110.06M | -13.54%-26.53M | 14.57%-21.01M | -8.08%-30.34M | -12.85%-32.18M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -52.32%15.56M | 189.17%42.2M | -88.08%8.56M | -239.97%-46.33M | 144.58%11.13M | 125.72%32.63M | -163.89%-47.32M | 218.52%71.81M | 188.92%33.1M | 86.60%-24.96M |
| Net PPE purchase and sale | 73.16%-168K | -33.33%-16K | 94.75%-20K | 47.83%-96K | 26.53%-36K | 45.42%-626K | 88.24%-12K | 47.30%-381K | 36.77%-184K | -58.06%-49K |
| Net investment purchase and sale | -52.71%15.73M | 189.23%42.21M | -88.12%8.58M | -238.91%-46.23M | 144.82%11.17M | 126.46%33.25M | -163.79%-47.31M | 210.26%72.19M | 190.12%33.28M | 86.62%-24.91M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -52.32%15.56M | 189.17%42.2M | -88.08%8.56M | -239.97%-46.33M | 144.58%11.13M | 125.72%32.63M | -163.89%-47.32M | 218.52%71.81M | 188.92%33.1M | 86.60%-24.96M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 145.77%94.78M | -98.01%691K | -90.45%84K | 3,422.22%94.01M | 0 | 1,222.71%38.57M | 4,271.91%34.71M | -61.03%880K | 140.65%2.67M | 283.54%303K |
| Net issuance payments of debt | --0 | ---- | ---- | ---- | ---- | 237.93%10M | ---- | ---- | ---- | ---- |
| Net common stock issuance | 278.53%93.58M | --0 | --0 | ---- | ---- | --24.72M | --24.72M | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | -72.71%1.21M | 21.87%691K | -90.45%84K | -83.85%431K | --0 | -0.16%4.42M | -28.59%567K | -61.03%880K | 389.72%2.67M | -63.45%303K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | 5.89%-575K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 145.77%94.78M | -98.01%691K | -90.45%84K | 3,422.22%94.01M | --0 | 1,222.71%38.57M | 4,271.91%34.71M | -61.03%880K | 140.65%2.67M | 283.54%303K |
| Net cash flow | ||||||||||
| Beginning cash position | -42.87%51.8M | -68.40%28.74M | 25.00%49.33M | -19.90%27.27M | -42.77%52.01M | -72.16%90.67M | 130.85%90.94M | 0.72%39.47M | -69.34%34.04M | -72.10%90.88M |
| Current changes in cash | 62.74%-14.48M | 121.92%8.58M | -139.44%-20.38M | 306.73%22.07M | 56.47%-24.74M | 83.45%-38.87M | -176.01%-39.14M | 24,627.27%51.68M | 107.55%5.43M | 73.52%-56.84M |
| End cash Position | -27.96%37.32M | -27.96%37.32M | -68.40%28.74M | 25.00%49.33M | -19.90%27.27M | -43.00%51.8M | -43.00%51.8M | 130.85%90.94M | 0.72%39.47M | -69.34%34.04M |
| Free cash flow | -12.92%-124.99M | -29.32%-34.32M | -35.79%-29.05M | 15.76%-25.71M | -11.41%-35.91M | -4.72%-110.69M | -13.10%-26.54M | 15.51%-21.39M | -7.62%-30.53M | -12.90%-32.23M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg